FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Otitis Media
• Pharyngitis
• Sinusitis
• Tonsillitis

Drugs mentioned

• Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)